Author:
Caponetto Patricia,Biedermann Tilo,Yazdi Amir S.,Fischer Jörg
Reference13 articles.
1. High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history;O'Neil;J Clin Oncol,2007
2. Fatal infusion reactions to cetuximab: role of immunoglobulin E-mediated anaphylaxis;Pointreau;J Clin Oncol,2012
3. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose;Chung;N Engl J Med,2008
4. Drug allergens and food—the cetuximab and galactose-α-1,3-galactose story;Berg;Ann Allergy Asthma Immunol,2014
5. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study;Price;Lancet Oncol,2014
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献